Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Drugs R D. 2021 Mar;21(1):39-64. doi: 10.1007/s40268-020-00329-w. Epub 2020 Dec 21.
Intravenous drug administration is associated with potential complications, such as phlebitis. The physiochemical characteristics of the infusate play a very important role in some of these problems.
The aim of this study was to standardize the dilutions of intravenous drugs most commonly used in hospitalized adult patients and to characterize their pH, osmolarity and cytotoxic nature to better guide the selection of the most appropriate vascular access.
The project was conducted in three phases: (i) standardization of intravenous therapy, which was conducted using a modified double-round Delphi method; (ii) characterization of the dilutions agreed on in the previous phase by means of determining the osmolarity and pH of each of the agreed concentrations, and recording the vesicant nature based on the information in literature; and (iii) algorithm proposal for selecting the most appropriate vascular access, taking into account the information gathered in the previous phases.
In total, 112 drugs were standardized and 307 different admixtures were assessed for pH, osmolarity and vesicant nature. Of these, 123 admixtures (40%), had osmolarity values >600 mOsm/L, pH < 4 or > 9, or were classified as vesicants. In these cases, selection of the most suitable route of infusion and vascular access device is crucial to minimize the risk of phlebitis-type complications.
Increasing safety of intravenous therapy should be a priority in the healthcare settings. Knowing the characteristics of drugs to assess the risk involved in their administration related to their physicochemical nature may be useful to guide decision making regarding the most appropriate vascular access and devices.
静脉内给药与潜在并发症相关,如静脉炎。输液的理化特性在其中一些问题中起着非常重要的作用。
本研究旨在对住院成年患者中最常用的静脉内药物进行稀释标准化,并对其 pH 值、渗透压和细胞毒性进行特征描述,以更好地指导选择最合适的血管通路。
该项目分三个阶段进行:(i)使用改良的双轮德尔菲法进行静脉治疗标准化;(ii)通过确定每个商定浓度的渗透压和 pH 值,并根据文献中的信息记录刺激性,对前一阶段商定的稀释液进行特征描述;(iii)根据前几个阶段收集的信息,提出选择最合适血管通路的算法建议。
共标准化了 112 种药物,并评估了 307 种不同的混合物的 pH 值、渗透压和刺激性。其中,123 种混合物(40%)的渗透压值>600 mOsm/L,pH 值<4 或>9,或被归类为刺激性药物。在这些情况下,选择最合适的输液途径和血管通路装置对于最小化静脉炎类型并发症的风险至关重要。
提高静脉治疗的安全性应该是医疗保健环境中的优先事项。了解药物的特性,评估与其理化性质相关的给药风险,可能有助于指导关于最合适的血管通路和装置的决策。